Cargando…

Preserved endothelial function in human obesity in the absence of insulin resistance

BACKGROUND: Insulin resistance (IR) is frequently associated with endothelial dysfunction and has been proposed to play a major role in cardiovascular disease (CVD). On the other hand, obesity has long been related to IR and increased CVD. However it is not known if IR is a necessary condition for e...

Descripción completa

Detalles Bibliográficos
Autores principales: El Assar, Mariam, Ruiz de Adana, Juan Carlos, Angulo, Javier, Pindado Martínez, María Luz, Hernández Matías, Alberto, Rodríguez-Mañas, Leocadio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016214/
https://www.ncbi.nlm.nih.gov/pubmed/24138787
http://dx.doi.org/10.1186/1479-5876-11-263
_version_ 1782315469094518784
author El Assar, Mariam
Ruiz de Adana, Juan Carlos
Angulo, Javier
Pindado Martínez, María Luz
Hernández Matías, Alberto
Rodríguez-Mañas, Leocadio
author_facet El Assar, Mariam
Ruiz de Adana, Juan Carlos
Angulo, Javier
Pindado Martínez, María Luz
Hernández Matías, Alberto
Rodríguez-Mañas, Leocadio
author_sort El Assar, Mariam
collection PubMed
description BACKGROUND: Insulin resistance (IR) is frequently associated with endothelial dysfunction and has been proposed to play a major role in cardiovascular disease (CVD). On the other hand, obesity has long been related to IR and increased CVD. However it is not known if IR is a necessary condition for endothelial dysfunction in human obesity, allowing for preserved endothelial function in obese people when absent. Therefore, the purpose of the study was to assess the relationship between IR and endothelial dysfunction in human obesity and the mechanisms involved. METHODS: Twenty non-insulin resistant morbid obese (NIR-MO), 32 insulin resistant morbid obese (IR-MO), and 12 healthy subjects were included. Serum concentrations of glucose, insulin, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), resistin and adiponectin were determined. IR was evaluated by HOMA-index. Endothelium-dependent relaxation to bradykinin (BK) in mesenteric microvessels was assessed in wire myograph. RESULTS: Serum IL-6, and TNF-α levels were elevated only in IR-MO patients while resistin was elevated and adiponectin reduced in all MO individuals. Mesenteric arteries from IR-MO, but not from NIR-MO subjects displayed blunted relaxation to BK. Vasodilatation was improved in IR-MO arteries by the superoxide scavenger, superoxide dismutase (SOD) or the mitochondrial-targeted SOD mimetic, mito-TEMPO. NADPH oxidase inhibitors (apocynin and VAS2870) and the nitric oxide synthase (NOS) cofactor, tetrahydrobiopterin failed to modify BK-induced vasodilatations. Superoxide generation was higher in vessels from IR-MO subjects and reduced by mito-TEMPO. Blockade of TNF-α with infliximab, but not inhibition of inducible NOS or cyclooxygenase, improved endothelial relaxation and decreased superoxide formation. CONCLUSIONS: Endothelial dysfunction is observed in human morbid obesity only when insulin resistance is present. Mechanisms involved include augmented mitochondrial superoxide generation, and increased systemic inflammation mediated by TNF-α. These findings may explain the different vascular risk of healthy vs unhealthy obesity.
format Online
Article
Text
id pubmed-4016214
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40162142014-05-10 Preserved endothelial function in human obesity in the absence of insulin resistance El Assar, Mariam Ruiz de Adana, Juan Carlos Angulo, Javier Pindado Martínez, María Luz Hernández Matías, Alberto Rodríguez-Mañas, Leocadio J Transl Med Research BACKGROUND: Insulin resistance (IR) is frequently associated with endothelial dysfunction and has been proposed to play a major role in cardiovascular disease (CVD). On the other hand, obesity has long been related to IR and increased CVD. However it is not known if IR is a necessary condition for endothelial dysfunction in human obesity, allowing for preserved endothelial function in obese people when absent. Therefore, the purpose of the study was to assess the relationship between IR and endothelial dysfunction in human obesity and the mechanisms involved. METHODS: Twenty non-insulin resistant morbid obese (NIR-MO), 32 insulin resistant morbid obese (IR-MO), and 12 healthy subjects were included. Serum concentrations of glucose, insulin, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), resistin and adiponectin were determined. IR was evaluated by HOMA-index. Endothelium-dependent relaxation to bradykinin (BK) in mesenteric microvessels was assessed in wire myograph. RESULTS: Serum IL-6, and TNF-α levels were elevated only in IR-MO patients while resistin was elevated and adiponectin reduced in all MO individuals. Mesenteric arteries from IR-MO, but not from NIR-MO subjects displayed blunted relaxation to BK. Vasodilatation was improved in IR-MO arteries by the superoxide scavenger, superoxide dismutase (SOD) or the mitochondrial-targeted SOD mimetic, mito-TEMPO. NADPH oxidase inhibitors (apocynin and VAS2870) and the nitric oxide synthase (NOS) cofactor, tetrahydrobiopterin failed to modify BK-induced vasodilatations. Superoxide generation was higher in vessels from IR-MO subjects and reduced by mito-TEMPO. Blockade of TNF-α with infliximab, but not inhibition of inducible NOS or cyclooxygenase, improved endothelial relaxation and decreased superoxide formation. CONCLUSIONS: Endothelial dysfunction is observed in human morbid obesity only when insulin resistance is present. Mechanisms involved include augmented mitochondrial superoxide generation, and increased systemic inflammation mediated by TNF-α. These findings may explain the different vascular risk of healthy vs unhealthy obesity. BioMed Central 2013-10-20 /pmc/articles/PMC4016214/ /pubmed/24138787 http://dx.doi.org/10.1186/1479-5876-11-263 Text en Copyright © 2013 El Assar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
El Assar, Mariam
Ruiz de Adana, Juan Carlos
Angulo, Javier
Pindado Martínez, María Luz
Hernández Matías, Alberto
Rodríguez-Mañas, Leocadio
Preserved endothelial function in human obesity in the absence of insulin resistance
title Preserved endothelial function in human obesity in the absence of insulin resistance
title_full Preserved endothelial function in human obesity in the absence of insulin resistance
title_fullStr Preserved endothelial function in human obesity in the absence of insulin resistance
title_full_unstemmed Preserved endothelial function in human obesity in the absence of insulin resistance
title_short Preserved endothelial function in human obesity in the absence of insulin resistance
title_sort preserved endothelial function in human obesity in the absence of insulin resistance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016214/
https://www.ncbi.nlm.nih.gov/pubmed/24138787
http://dx.doi.org/10.1186/1479-5876-11-263
work_keys_str_mv AT elassarmariam preservedendothelialfunctioninhumanobesityintheabsenceofinsulinresistance
AT ruizdeadanajuancarlos preservedendothelialfunctioninhumanobesityintheabsenceofinsulinresistance
AT angulojavier preservedendothelialfunctioninhumanobesityintheabsenceofinsulinresistance
AT pindadomartinezmarialuz preservedendothelialfunctioninhumanobesityintheabsenceofinsulinresistance
AT hernandezmatiasalberto preservedendothelialfunctioninhumanobesityintheabsenceofinsulinresistance
AT rodriguezmanasleocadio preservedendothelialfunctioninhumanobesityintheabsenceofinsulinresistance